[
  {
    "ts": null,
    "headline": "This High-Yield Dividend Stock Is Staging a Comeback. Should You Buy Shares Now?",
    "summary": "CVS Health’s blowout Q2 2025 results, boosted earnings guidance, and “Strong Buy” analyst consensus make it a standout comeback story among high-yield dividend stocks.",
    "url": "https://finnhub.io/api/news?id=b839cfd5e4f734003a37dec069d658860afd1522e019e913bccbcfde6377763c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754350202,
      "headline": "This High-Yield Dividend Stock Is Staging a Comeback. Should You Buy Shares Now?",
      "id": 136205959,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health’s blowout Q2 2025 results, boosted earnings guidance, and “Strong Buy” analyst consensus make it a standout comeback story among high-yield dividend stocks.",
      "url": "https://finnhub.io/api/news?id=b839cfd5e4f734003a37dec069d658860afd1522e019e913bccbcfde6377763c"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corp. stock underperforms Monday when compared to competitors",
    "summary": "CVS Health Corp. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=e129764d6c805d36db9b66018cdaddf66090ad7aba3d0842efd143bc6852e01b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754325720,
      "headline": "CVS Health Corp. stock underperforms Monday when compared to competitors",
      "id": 136253958,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Health Corp. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=e129764d6c805d36db9b66018cdaddf66090ad7aba3d0842efd143bc6852e01b"
    }
  },
  {
    "ts": null,
    "headline": "4 Value Stocks to Shield Amid Labor Market and Trade Worries",
    "summary": "CVS, ITGR, ASB and FNB emerge as value picks amid trade tensions and labor market concerns, thanks to strong cash flow metrics.",
    "url": "https://finnhub.io/api/news?id=daa79e74cf64fd733c39e9298f60198320403c46b25f614223a907a7f74fa544",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754314620,
      "headline": "4 Value Stocks to Shield Amid Labor Market and Trade Worries",
      "id": 136200463,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS, ITGR, ASB and FNB emerge as value picks amid trade tensions and labor market concerns, thanks to strong cash flow metrics.",
      "url": "https://finnhub.io/api/news?id=daa79e74cf64fd733c39e9298f60198320403c46b25f614223a907a7f74fa544"
    }
  },
  {
    "ts": null,
    "headline": "Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?",
    "summary": "According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
    "url": "https://finnhub.io/api/news?id=19cdcc847d17bc0efef254d26fe586996536480126613d976ac8d110c520bd89",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754314202,
      "headline": "Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?",
      "id": 136200464,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
      "url": "https://finnhub.io/api/news?id=19cdcc847d17bc0efef254d26fe586996536480126613d976ac8d110c520bd89"
    }
  },
  {
    "ts": null,
    "headline": "Lilly’s Push to $1 Trillion Derailed by Trade Risks and Obesity Drug Speedbumps",
    "summary": "(Bloomberg) -- A year ago, Eli Lilly & Co. was poised to become the first pharmaceutical company to register a trillion-dollar market valuation. It still hasn’t cracked that ceiling.Most Read from BloombergSeeking Relief From Heat and Smog, Cities Follow the WindChicago Curbs Hiring, Travel to Tackle $1 Billion Budget HoleNYC Mayor Adams Gives Bally’s Bronx Casino Plan a Second ChanceInstead, a series of weak earnings reports, a setback for its obesity drug and threats of sky-high tariffs have t",
    "url": "https://finnhub.io/api/news?id=898c354f6d01951df2f7b782b1f22cde1986fb5dca64e9e678dd3044db2963e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754305201,
      "headline": "Lilly’s Push to $1 Trillion Derailed by Trade Risks and Obesity Drug Speedbumps",
      "id": 136197848,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- A year ago, Eli Lilly & Co. was poised to become the first pharmaceutical company to register a trillion-dollar market valuation. It still hasn’t cracked that ceiling.Most Read from BloombergSeeking Relief From Heat and Smog, Cities Follow the WindChicago Curbs Hiring, Travel to Tackle $1 Billion Budget HoleNYC Mayor Adams Gives Bally’s Bronx Casino Plan a Second ChanceInstead, a series of weak earnings reports, a setback for its obesity drug and threats of sky-high tariffs have t",
      "url": "https://finnhub.io/api/news?id=898c354f6d01951df2f7b782b1f22cde1986fb5dca64e9e678dd3044db2963e7"
    }
  },
  {
    "ts": null,
    "headline": "Zacks Investment Ideas feature highlights: CVS Health, Johnson & Johnson and Tenet Healthcare",
    "summary": "CVS, JNJ, and Tenet Healthcare shine as defensive picks with strong earnings momentum and attractive valuations.",
    "url": "https://finnhub.io/api/news?id=9712ee381ad80a17d1634e5f229bcc7f96e971f0fb79426b7a14e371833904f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754298060,
      "headline": "Zacks Investment Ideas feature highlights: CVS Health, Johnson & Johnson and Tenet Healthcare",
      "id": 136197866,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS, JNJ, and Tenet Healthcare shine as defensive picks with strong earnings momentum and attractive valuations.",
      "url": "https://finnhub.io/api/news?id=9712ee381ad80a17d1634e5f229bcc7f96e971f0fb79426b7a14e371833904f1"
    }
  }
]